Déjérine-Sottas neuropathy is associated with a de novo PMP22 mutation
✍ Scribed by Linda J. Valentijn; Robert A. Ouvrier; Norbert H. A. Van Den Bosch; Pieter A. Bolhuis; Frank Baas; Garth A. Nicholson
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 588 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
✦ Synopsis
We identified a de novo mutation in the peripheral myelin protein (PMP22) gene of a patient with Dkjkrine-Sottas neuropathy. Single-stranded conformation analysis of PCR-amplified D N A fragments showed an additional fragment for exon 1 in the patient, which was absent in the unaffected parents. Sequence analysis showed a de novo point mutation C8'-+A that results in an amino acid substitution His 12Gln in the first transmembrane domain of PMP22. This provides further evidence that sporadic cases of Dkjjerine-Sottas neuropathy can be due to dominant single base substitutions.
📜 SIMILAR VOLUMES
We studied a 25-year-old black woman with healthy parents and her 2-year, 11-month-old son. Her motor development was delayed and she started to walk with support when she was 6 years old. She never walked independently and had always used a wheelchair. Neurological evaluation showed severe weakness
Dejerine-Sottas syndrome (DSS), or hereditary motor and sensory neuropathy (HMSN) type 111, is a severe hypertrophic demyelinating neuropathy with infantile onset. The clinical symptoms are similar to those found in Charcot-Marie-Tooth disease type 1 (CMT1) or HMSN type I patients, but they are more